Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 9, 2007

Nanoviricides and Walter Reed Team Up to Fight Dengue Fever

  • NanoViricides signed a CRADA with the Walter Reed Army Institute of Research (WRAIR). The joint R&D effort will focus on creating new treatments for dengue fever using NanoViricides’ virus-killing nanomedicine technology.

    "This collaboration will leverage Walter Reed’s extensive experience in dengue fever research with our unique nanoviricide™ technology platform for creating antiviral medications," says president, Anil Diwan.

    The company’s TheraCour technologies are used to develop nanotechnology-based targeted antiviral therapeutics.  



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »